Nephrology Dialysis Transplantation logo Oxford University Press logo

Nephrology Dialysis Transplantation is one of the world's leading journals devoted to original clinical and laboratory research in nephrology, dialysis and transplantation. Published monthly, the journal provides an essential resource for researchers and clinicians throughout the world.

Publisher: Oxford University Press

Volume 18, Supplement 1, March 2003
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

< previous issue | next issue > | all issues

Introduction
pp. iii1-iii1(1)
Authors: Kiyoshi Kurokawa; Masafumi Fukagawa

Control of parathyroid cell growth by calcimimetics
pp. iii13-iii17(1)
Authors: Michihito Wada; Nobuo Nagano

Adenovirus-mediated functional gene transfer into parathyroid cells in vivo and in vitro
pp. iii18-iii22(1)
Authors: Yoshiko Iwasaki; Takatoshi Kakuta; Hiroaki Haruguchi; Naoko Fukuda; Kiyoshi Kurokawa; Masafumi Fukagawa

Medical management of secondary hyperparathyroidism in chronic renal failure
pp. iii2-iii8(1)
Author: William G. Goodman

Role of parathyroid intervention in the management of secondary hyperparathyroidism
pp. iii23-iii26(1)
Authors: Masafumi Fukagawa; Shohei Nakanishi

Ultrasonographic diagnosis of parathyroid glands and percutaneous ethanol injection therapy
pp. iii27-iii30(1)
Author: Masafumi Kitaoka

Guidelines for percutaneous ethanol injection therapy of the parathyroid glands in chronic dialysis patients
pp. iii31-iii33(1)
Authors: Masafumi Fukagawa; Masafumi Kitaoka; Yoshihiro Tominaga; Tadao Akizawa; Takatoshi Kakuta; Noritaka Onoda; Fumihiko Koiwa; Shigeru Yumita; Kiyoshi Kurokawa for the Japanese Society for Parathyroid Intervention

Evaluation of blood supply to the parathyroid glands in secondary hyperparathyroidism compared with histopathology
pp. iii34-iii37(1)
Authors: Noritaka Onoda; Satoshi Kurihara; Yusei Sakurai; Kazuhiro Owada; Eiichi Osono; Hideki Adachi; Masaru Suga; Hideo Yoneshima

Percutaneous calcitriol injection therapy (PCIT) for secondary hyperparathyroidism: multicentre trial
pp. iii38-iii41(1)
Authors: M. Kitaoka; N. Onoda; H. Kitamura; F. Koiwa; M. Tanaka; M. Fukagawa

Effect of percutaneous calcitriol injection therapy on secondary hyperparathyroidism in uraemic patients
pp. iii42-iii46(1)
Authors: Kazuhiro Shiizaki; Shigeo Negi; Masahide Mizobuchi; Ikuji Hatamura; Nobuhiko Narukawa; Toshifumi Sakaguchi; Yukiko Kitabata; Shinji Sumikado; Tadao Akizawa

Efficacy of direct injection of calcitriol into the parathyroid glands in uraemic patients with moderate to severe secondary hyperparathyroidism
pp. iii47-iii49(1)
Authors: Shohei Nakanishi; Shozo Yano; Rikako Nomura; Tatsuo Tsukamoto; Yasushi Shimizu; Jeongsoo Shin; Masafumi Fukagawa

Surgical verification of percutaneous maxacalcitol injection therapy on enlarged parathyroid glands in chronic dialysis patients
pp. iii50-iii52(1)
Authors: Hiroyasu Yamamoto; Naohiko Katoh; Hiroshi Takeyama; Masato Ikeda; Keitaro Yokoyama; Takashi Shigematsu; Yoshindo Kawaguchi; Tatsuo Hosoya

Time course of change in calcium × phosphorus product after percutaneous ethanol injection therapy
pp. iii53-iii57(1)
Authors: Fumihiko Koiwa; Takeshi Hasegawa; Ichiro Kojima; Terukuni Ideura

Long-term (3 years) prognosis of parathyroid function in chronic dialysis patients after percutaneous ethanol injection therapy guided by colour Doppler ultrasonography
pp. iii58-iii61(1)
Authors: Reika Tanaka; Takatoshi Kakuta; Tomotaka Fujisaki; Shinichi Tanaka; Hideto Sakai; Kiyoshi Kurokawa; Akira Saito

Intervention for recurrent secondary hyperparathyroidism from a residual parathyroid gland
pp. iii62-iii64(1)
Author: Shigeru Yumita

Re-operation is frequently required when parathyroid glands remain after initial parathyroidectomy for advanced secondary hyperparathyroidism in uraemic patients
pp. iii65-iii70(1)
Authors: Yoshihiro Tominaga; Akio Katayama; Tetsuhiko Sato; Susumu Matsuoka; Norihiko Goto; Toshihito Haba; Yatsuka Hibi; Masahiro Numano; Toshihiro Ichimori; Kazuharu Uchida

Long-term prognosis of parathyroid function for chronic dialysis patients after minimally invasive radioguided parathyroidectomy (MIRP)
pp. iii71-iii75(1)
Authors: Takatoshi Kakuta; Yutaka Suzuki; Futoshi Tadaki; Reika Tanaka; Shinichi Tanaka; Hideto Sakai; Kiyoshi Kurokawa; Akira Saito

Combined radioguided parathyroidectomy and intravenous vitamin D therapy for the treatment of uraemic hyperparathyroidism
pp. iii76-iii78(1)
Authors: Yuko Oyama; J. James Kazama; Hiroki Maruyama; Ichiei Narita; Chizuko Kanbayashi; Yu Koyama; Tsukasa Omori; Katsuyoshi Hatakeyama; Fumitake Gejyo

Molecular targets of hyperphosphataemia in chronic renal failure
pp. iii79-iii80(1)
Authors: Ken-Ichi Miyamoto; Mikiko Ito; Hiriko Segawa; Masashi Kuwahata

Sevelamer hydrochloride, a calcium-free phosphate binder, inhibits parathyroid cell proliferation in partially nephrectomized rats
pp. iii81-iii85(1)
Authors: Nobuo Nagano; Sonoe Miyata; Sachiko Obana; Nami Kobayashi; Megumi Abe; Naoshi Fukushima; Michihito Wada

Phosphate overload accelerates vascular calcium deposition in end-stage renal disease patients
pp. iii86-iii89(1)
Authors: Takashi Shigematsu; Takashi Kono; Kenichi Satoh; Keitaro Yokoyama; Toyohiko Yoshida; Tatsuo Hosoya; Kohji Shirai

Parathyroid cell growth in patients with advanced secondary hyperparathyroidism: vitamin D receptor and cyclin-dependent kinase inhibitors, p21 and p27
pp. iii9-iii12(1)
Authors: Masanori Tokumoto; Kazuhiko Tsuruya; Kyoichi Fukuda; Hidetoshi Kanai; Shoji Kuroki; Hideki Hirakata; Mitsuo Iida

Colestimide can be used as a phosphate binder to treat uraemia in end-stage renal disease patients
pp. iii90-iii93(1)
Authors: Toshiyuki Date; Takashi Shigematsu; Yoshiteru Kawashita; Nobuyoshi Satake; Kyoko Morita

Role of osteoclastic dysfunction in the development of renal bone disease
pp. iii94-iii96(1)
Authors: Junichiro James Kazama; Fumitake Gejyo; Takeshi Kurosawa; Masafumi Fukagawa

IRMA (whole PTH) is a more useful assay for the effect of PTH on bone than the Allegro intact PTH assay in CAPD patients with low bone turnover marker
pp. iii97-iii98(1)
Authors: Yudo Tanno; Keitaro Yokoyama; Masaaki Nakayama; Akihiko Katoh; Hiroyasu Yamamoto; Yoshiko Iwasaki; Tom Cantor; Masafumi Fukagawa; Takashi Shigematsu; Tatsuo Hosoya

< previous issue | next issue > | all issues

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A